Mark Wirth
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Genetics top 10%
- Glioma Diagnosis and Treatment
Papers in
-
- Plant Toxicity and Pharmacological Properties 1
- Genetics 3
- Glioma Diagnosis and Treatment 2
- Co-authors
- Kevin B. Alton (7 shared papers)Stephen W.J. Wang (1 shared paper)Ian Knemeyer (1 shared paper)Jaime A. Yáñez (1 shared paper)Paul Statkevich (4 shared papers)Vijay Batra (2 shared papers)Margaret Dugan (1 shared paper)David L. Cutler (1 shared paper)
- Journals
- Xenobiotica (3 papers)Journal of Pharmaceutical and Biomedical Analysis (1 paper)European Journal of Pharmacology (1 paper)The Journal of Clinical Pharmacology (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Mark Wirth
9 papers receiving 643 citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 125
- Genetics 128
- Pharmacology 59
- Drug Discovery 1
- Biomaterials 75
Countries citing papers authored by Mark Wirth
This map shows the geographic impact of Mark Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wirth more than expected).
Fields of papers citing papers by Mark Wirth
This network shows the impact of papers produced by Mark Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wirth. The network helps show where Mark Wirth may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 208 | |
| 2 | Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. | 1999 | 194 |
| 3 | 2000 | 79 | |
| 4 | 2004 | 50 | |
| 5 | 2011 | 43 | |
| 6 | 2007 | 28 | |
| 7 | 1999 | 25 | |
| 8 | 2007 | 22 | |
| 9 | 2015 | 14 |
About Mark Wirth
Mark Wirth is a scholar working on Molecular Biology, Genetics, Pharmacology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 663 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Glioma Diagnosis and Treatment (2 papers), Metabolism and Genetic Disorders (1 paper), Inflammatory mediators and NSAID effects (1 paper), Colorectal Cancer Treatments and Studies (1 paper), Boron Compounds in Chemistry (1 paper) and Plant Toxicity and Pharmacological Properties (1 paper). The work is most often cited by research in Pharmaceutical Science (125 citations), Genetics (128 citations), Pharmacology (59 citations), Drug Discovery (1 citation) and Biomaterials (75 citations). Mark Wirth has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Kevin B. Alton, Stephen W.J. Wang, Ian Knemeyer, Jaime A. Yáñez, Paul Statkevich, Vijay Batra, Margaret Dugan, David L. Cutler, Sharyn D. Baker and S E Sartorius. Their work appears in journals such as Xenobiotica, Journal of Pharmaceutical and Biomedical Analysis, European Journal of Pharmacology, The Journal of Clinical Pharmacology and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.